NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA
source: pixabay.com

NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA

According to a press release from the rare liver disease company Albireo Pharma, Inc., the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for odevixibat.…

Continue Reading NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA
Study Reveals Gene Therapy as a Possible Tuberous Sclerosis Complex Treatment
source: pixabay.com

Study Reveals Gene Therapy as a Possible Tuberous Sclerosis Complex Treatment

According to a story from news-medical.net, a team of scientists affiliated with Massachusetts General Hospital has conducted a study revealing that gene therapy could be an effective treatment for tuberous…

Continue Reading Study Reveals Gene Therapy as a Possible Tuberous Sclerosis Complex Treatment
Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial
source: pixabay.com

Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial

According to a story from dernieresactus.fr, the biopharmaceutical company Inventiva has recently announced plans for its upcoming phase III clinical trial. This trial will investigate its lead candidate lanifibranor as…

Continue Reading Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial
Prenatal Diagnosis of Pierre Robin Sequence: an Interview with Dr. Cory Resnick
source: pixabay.com

Prenatal Diagnosis of Pierre Robin Sequence: an Interview with Dr. Cory Resnick

Dr. Cory M. Resnick, Oral & Maxillofacial Surgeon at Boston Children’s Hospital and Assistant Professor at Harvard Medical School, describes the exciting progress he has made on the Prenatal Diagnosis of Pierre Robin Sequence. Interview by Philippe Pakter, chairman of Pierre Robin Europe.

(more…)

Continue Reading Prenatal Diagnosis of Pierre Robin Sequence: an Interview with Dr. Cory Resnick